Aspect Biosystems

Bioprinting Strategies: The Robin Hoods of Wake Forest

Rue to those aspiring to be modern-day Robin Hoods of Wake Forest: the path to riches in bioprinting is fraught with challenges. It’s perplexing that the media has not fully…

Canadian Government Invests $75M More in Aspect Biosystems

Canadian bioprinting startup Aspect Biosystems has received a $72.75 million investment from Canada and the province of British Columbia. This supports earlier investments amounting to $200 million in Aspect’s technology…

Featured

Aspect Biosystems Strikes $2.6B Bioprinted Tissue Deal with Novo Nordisk

Bioprinting collaborations are heating up in 2023. In one of the biggest moves of the bioprinting industry, Canadian startup Aspect Biosystems and Danish pharma giant Novo Nordisk (CPH: NOVO-B) struck…

Featured

The 19 Most Famous Angel Investors in 3D Printing

You may have the greatest idea in the world and just need that small investment of faith to launch it into a fully-fledged business. If a single individual, perhaps with…

Aspect Biosystems Partners With JDRF to Treat Diabetes

Canadian biotech startup Aspect Biosystems, founded and led by biomedical engineer Tamer Mohamed, has partnered with the nonprofit organization Juvenile Diabetes Research Foundation (JDRF) to develop bioengineered tissue therapeutics to…

Dream 3D Printing Mergers & Acquisitions: What if Henkel Acquired…

Inspired in part by the SPAC mergers of VELO3D with Jaws, Markforged with one, and Rocket Lab with Vector Acquisition Corporation, as well as the acquisition of EnvisionTEC by Desktop Metal, and…

Bioprinting Researchers: Apply to Receive an Aspect Biosystem’s RX1 Bioprinter

For the second year in a row, Aspect Biosystems announced applications are open for its RX1 Bioprinter Grant Program. Designed to support researchers who need access to advanced 3D bioprinting…

Featured

AMS 2021: Deconstructing the Timeline to Bioprinted Organs

Automation, healthcare, metal additive manufacturing (AM), and bioprinting were the four big topics discussed at the 2021 Additive Manufacturing Strategies (AMS) summit. The two-day virtual event gathered experts for panel…

Aspect Biosystems to Deliver Two Bioprinters to Researchers via New Grant Program

Pioneering microfluidic bioprinting company Aspect Biosystems launched a new grant program for research labs, enhancing the use of 3D bioprinting technology. The Vancouver-based biotechnology firm will choose two winners that…

3D Printing Webinar and Virtual Event Roundup, September 20, 2020

Buckle up, we’ve got a lot of webinars and online events to tell you about this week! Ceramics Expo Connect starts on Monday, which is the same day that IMTS…

Interview with Tamer Mohamed of Aspect Biosystems on Advancing Tissue Therapeutics

While attending The University of British Columbia (UBC), Tamer Mohamed, along with fellow graduate student Simon Beyer, began working at the Walus Laboratory on the development of a novel microfluidics-based…

Aspect Biosystems is Creating Opportunities in Biotech

In the coming decade, the 3D bioprinting community could witness some of the most important technology advancements we have ever seen. Researchers, laboratories, universities, companies and the young generations of…

Aspect Biosystems Heads $2.2 Million Project with New Microfluidic 3D Bioprinting Platform

Aspect Biosystems, headquartered in Vancouver, has created a new microfluidic 3D bioprinting platform to further the progress of tissue engineering. In a collaboration with Merck, GSK, and McGill University’s Goodman…

Aspect Biosystems and Maastricht University Begin Joint 3D Bioprinting Research Collaboration

The Institute for Technology-Inspired Regenerative Medicine (MERLN) at Maastricht University in the Netherlands works to be a leader in the biomedical engineering field by training an interdisciplinary generation of scientists and…

Aspect Biosystems Receives $1 Million Investment to Help Commercialize Its Lab-on-a-Printer 3D Bioprinting Platform

This week, Genome British Columbia (BC), which leads genomics innovation on the West Coast of Canada, announced that it has invested $1 million in funding to Aspect Biosystems, a leading Canadian…

German and Canadian Organizations Partner to Develop 3D Printed Contractile Tissue

It’s been a big week for bioprinting, with news of planned 3D printed organs coming from both Prellis Biologics and BIOLIFE4D. The bioprinting world is one that doesn’t slow down, and…

11 Companies Leading the 3D Bioprinting Space

Undoubtedly one of the most exciting areas within the 3D printing space is that of bioprinting. Using layer-by-layer fabrication methods, a number of companies are in the process of pushing…

Aspect Biosystems Announces Seed Funding & Major Deals Involving Their 3D Bioprinting Initiatives

The 3D bioprinting space is heating up. As companies like Organovo rapidly develop new forms of printable human tissue and bring those tissues to market, other smaller companies are joining…

Aspect Biosystems of Vancouver 3D Prints Human Cells, Now a Finalist in $300k Competition

Was there ever a point in history where speculation regarding the possibilities of scientific innovation wasn’t greeted by some as implausible in the least, dangerous, or even heretical at worst?…